Overcoming barriers to oral contraception in Italy an expert opinion to empower women

References

• ESHRE Capri Workshop Group. Why after 50 years of effective contraception do we still have unintended pregnancy? A European perspective. Hum Reprod. 2018;33:1–6.
   PubMed Web of Science ®Google Scholar
• Istituto Nazionale di Statistica (Istat) [Internet]. Health for All. [updated December 2022]. Available from: https://www.istat.it/it/archivio/14562.
   Google Scholar
• International Planned Parenthood Federation European Network (IPPF EN). Barometer of Women’s Access to Modern Contraceptive Choice in 16 EU Countries; 2015. Available from: https://europe.ippf.org/resource/womens-access-modern-contraceptive-choice-barometer-2015.
   Google Scholar
• Fondazione Onda Osservatorio nazionale sulla salute della donna e di genere. Donne e accesso alla contraccezione ormonale. Focus contraccezione orale di emergenza; 2019. Available from: https://fondazioneonda.it/ondauploads/2020/11/Documento-istituzionale-contraccezione.pdf
   Google Scholar
• Arisi E, Bauer C, Farris M, et al. The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and Spain. Eur J Contracept Reprod Health Care. 2022;27(6):494–503. doi:10.1080/13625187.2022.2128643.
   PubMed Web of Science ®Google Scholar
• Ciccarone A, Begovic I, Bruno GM, et al. Il potenziale impatto della riclassificazione della pillola progestinica sulle gravidanze non pianificate in italia. Clinicoecon Outcomes Res. 2022;17:249–262.
   Google Scholar
• Medicines and Healthcare products Regulatory Agency [Internet]. First progestogen-only contraceptive pills to be available to purchase from pharmacies; 2021. Available from: https://www.gov.uk/government/news/first-progesterone-only-contraceptive-pills-to-be-available-to-purchase-from-pharmacies.
   Google Scholar
• Farris M, Arisi E, Mirjalili N, et al. Attitudes of women and pharmacists on the opportunity to obtain a progestogen-only pill over the counter – Italian outcomes. Gynecol Endocrinol. 2023;39(1):2206992.
   Google Scholar
• Haakenstad A, Angelino O, Irvine CMS, et al. Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10348):295–327. doi:10.1016/S0140-6736(22)00936-9.
   PubMed Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404. doi:10.1016/j.contraception.2011.01.021.
   PubMed Web of Science ®Google Scholar
• DeMaria AL, Rivera S, Ramos-Ortiz J, et al. It’s just a very personal thing’: contraceptive influences and decision making among women living in Italy. Eur J Contracept Reprod Health Care. 2019;24(3):198–205. doi:10.1080/13625187.2019.1615616.
   PubMed Web of Science ®Google Scholar
• Pizzi E, Spinelli A, Andreozzi S, et al. Rapporto ISTISAN 20/35 - Progetto “Studio Nazionale Fertilità”: i risultati delle cinque indagini [Internet]. 2020. Available from: https://www.iss.it/documents/20126/0/20-35+web.pdf/34bba33d-3753-266f-a165-fc8e1e8dfbaf?t=1614671375805.
   Google Scholar
• Meier S, Giannone A, Umberger A, et al. Messaging and access strategies for improving emergency contraceptive knowledge and uptake among Italians. Eur J Contracept Reprod Health Care. 2022;27(2):166–172. doi:10.1080/13625187.2021.2008346.
   PubMed Web of Science ®Google Scholar
• Mastroiacovo P, Nilsen RM, Leoncini E, et al. Prevalence of maternal preconception risk factors: an italian multicenter survey. Ital J Pediatr. 2014;40(1):91. doi:10.1186/s13052-014-0091-5.
   PubMedGoogle Scholar
• Mohllajee AP, Curtis KM, Morrow B, et al. Pregnancy intention and its relationship to birth and maternal outcomes. Obstet Gynecol. 2007;109(3):678–686. doi:10.1097/01.AOG.0000255666.78427.c5.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Abalos V, Apter D, et al. Targeting factors for change: contraceptive counselling and care of female adolescents. Eur J Contracept Reprod Health Care. 2016;21(6):417–430. doi:10.1080/13625187.2016.1237629.
   PubMed Web of Science ®Google Scholar
• Istituto Nazionale di Statistica (Istat) [Internet]. La salute riproduttiva della donna; 2017. Available from: https://www.istat.it/it/files/2018/03/La-salute-riproduttiva-della-donna.pdf
   Google Scholar
• Zennaro C. Wired [Internet]. Il Lazio e le altre regioni in cui la pillola anticoncezionale è gratuita. Available from: https://www.wired.it/article/pillola-anticoncezionale-gratis-dove-lazio-regioni/.
   Google Scholar
• United Nations Committee on Economic Social and Cultural Rights. General comment no. 22 on the right to sexual and reproductive health [Internet]. 2016. Available from: https://www.escr-net.org/resources/general-comment-no-22-2016-right-sexual-and-reproductive-health.
   Google Scholar
• Merki-Feld GS, Caetano C, Porz TC, et al. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study. Eur J Contracept Reprod Health Care. 2018;23(3):183–193. doi:10.1080/13625187.2018.1465546.
   PubMed Web of Science ®Google Scholar
• Caserta D, Matteucci E, Ralli E, et al. Attitudes towards abortion in Italian women: socio-economic trends and epidemiological features. Clin Exp Obstet Gynecol. 2016;43(4):578–583. doi:10.12891/ceog3042.2016.
   PubMed Web of Science ®Google Scholar
• Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care. 2010;15(sup2):S42–S53. doi:10.3109/13625187.2010.533002.
   PubMed Web of Science ®Google Scholar
• Grossman D. Over-the-Counter access to oral contraceptives. Obstet Gynecol Clin North Am. 2015;42(4):619–629. doi:10.1016/j.ogc.2015.07.002.
   PubMed Web of Science ®Google Scholar
• Teal S, Edelman A. Contraception selection, effectiveness, and adverse effects: a review. JAMA. 2021;326(24):2507–2518. doi:10.1001/jama.2021.21392.
   PubMed Web of Science ®Google Scholar
• Monterrosa-Castro A, Redondo-Mendoza V, Monterrosa-Blanco A. Current knowledge of progestin-only pills. Electron J Gen Med. 2021;18(6):em320. doi:10.29333/ejgm/11217.
   Web of Science ®Google Scholar
• Dutton C, Kim R, Janiak E. Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database. Contraception. 2021;103(5):367–370. doi:10.1016/j.contraception.2021.01.010.
   PubMed Web of Science ®Google Scholar
• White K, Potter JE, Hopkins K, et al. Contraindications to progestin-only oral contraceptive pills among reproductive-aged women. Contraception. 2012;86(3):199–203. doi:10.1016/j.contraception.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Zuniga C, Blanchard K, Harper CC, et al. Effectiveness and efficacy rates of progestin-only pills: a comprehensive literature review. Contraception. 2023;119:109925. doi:10.1016/j.contraception.2022.109925.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed.; 2009. Available from: https://apps.who.int/iris/handle/10665/44433.
   Google Scholar
• Curtis KM, Tepper NK, Jatlaoui TC, et al. US medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(3):1–103. doi:10.15585/mmwr.rr6503a1.
   Web of Science ®Google Scholar
• FSRH Guideline. Progestogen-only pills. BMJ Sex Reprod Health. 2022;48(Suppl(1):1–75.
   Google Scholar
• IQVIA Midas. 2021, data on file.
   Google Scholar
• Milsom I, Korver T. Ovulation incidence with oral contraceptives: a literature review. J Fam Plann Reprod Health Care. 2008;34(4):237–246. doi:10.1783/147118908786000451.
   PubMedGoogle Scholar
• Faculty of Sexual and Reproductive Healthcare [Internet]. FSRH, RCOG and RPS support provision of the progestogen-only contraceptive pill in pharmacies [cited 2021 Feb 21]; Available from: https://www.fsrh.org/news/fsrh-rcog–rps-statement-progestogen-only-pill-mhra-consultation
   Google Scholar
• Irish Pharmacy Union [Internet]. Ireland Should Follow UK Example On Contraceptives – Pharmacists [cited 2021 Jul 21]. Available from: https://ipu.ie/communication/ireland-should-follow-uk-example-on-contraceptives-pharmacists/.
   Google Scholar
• Le Collectif de Pharmaciens and Le Planning Familial [Internet]. Laboratoires pharmaceutiques, mettez sur le marché une pilule sans ordonnance [Pharmaceutical Laboratorists, put on the market a pill without prescription] [cited 2017]. Available from: https://www.change.org/p/pour-une-pilule-contraceptive-sans-ordonnance
   Google Scholar
• Satué de Velasco E, Armenteros del Olmo L, Blasco Martínez MR, et al. Documento de consenso Para indicación y dispensación de desogestrel (DSG) 75 mcg en anticoncepción sin prescripción médica. [Consensus document on indication and dispensing of desogestrel (DSG) 75 mcg as a contraceptive without medical prescription]. Madrid. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria; 2022.
   Google Scholar
• Over-the-Counter access to hormonal contraception: ACOG Committee Opinion, Number 788. Obstet Gynecol. 2019;134(4):e96–e105.
   PubMed Web of Science ®Google Scholar
• WHO guideline on self-care interventions for health and well-being, 2022 revision. Geneva: World Health Organization; 2022.
   Google Scholar
• Rafie S, Kelly S, Gray EK, et al. Provider opinions regarding expanding access to hormonal contraception in pharmacies. Womens Health Issues. 2016;26(2):153–160. doi:10.1016/j.whi.2015.09.006.
   PubMed Web of Science ®Google Scholar
• Borg S, Narasimhan M, Wuliji T. Mobile learning to support health workers in pharmacies in expanding access to over-the-counter contraceptives: the World Health Organization Academy Learning Programme. Sex Reprod Health Matters. 2022;30(1):2089084.
   PubMedGoogle Scholar
• New Zealand Medicines and Medical Devices Safety Authority [Internet]. Minutes of the 57th meeting of the Medicines Classification Committee held in Wellington on Tuesday 1 November 2016 at 9:30 am. Available from: https://www.medsafe.govt.nz/profs/class/Minutes/2016-2020/mccMin1Nov2016.htm
   Google Scholar
• Canadian Pharmacist Association [Internet]. More than one million Canadian women continue to face barriers accessing birth control and other health care services. Strong support across the country for pharmacists to help improve access; [cited 2020 Mar 6]. Available from: https://www.pharmacists.ca/news-events/news/more-than-one-million-canadian-women-continue-to-face-barriers-accessing-birth-control-and-other-health-care-services/.
   Google Scholar
• Schaapveld A, van der Vlugt I, Rutger [Internet]. Contraceptive Knowledge file [cited 2018 Oct]. Available from: https://rutgers.international/wp-content/uploads/2021/09/Knowledgefile-contraceptives.pdf
   Google Scholar
• Medicine & Healthcare Products Regulatory Agency [Internet]. Consultation outcome Hana public assessment report. Updated 8 July 2021. Available from: https://www.gov.uk/government/consultations/hana-75-microgram-film-coated-tablets-desogestrel-public-consultation/outcome/hana-public-assessment-report.
   Google Scholar
• Ciliberti R, Bragazzi NL, Bonsignore A. The implementation of the professional role of the community pharmacist in the immunization practices in Italy to counteract vaccine hesitancy. Pharmacy (Basel). 2020;8(3):155. doi:10.3390/pharmacy8030155.
   PubMedGoogle Scholar
• Portolano Cavallo [Internet]. Stefanini E, The “Pharmacy of Services” becomes more and more real [cited 2021 Apr 9]. Available from: https://portolano.it/en/newsletter/portolano-cavallo-inform-life-sciences/the-pharmacy-of-services-becomes-more-and-more-real
   Google Scholar
• El Bizri L, Jarrar LG, Ali WKA, et al. The role of community pharmacists in increasing access and use of self-care interventions for sexual and reproductive health in the Eastern Mediterranean Region: examples from Egypt, Jordan, Lebanon and Somalia. Health Res Policy Syst. 2021;19(Suppl 1):49. doi:10.1186/s12961-021-00695-0.
   PubMed Web of Science ®Google Scholar
• Boog K, Chen ZE, Cameron S. Sexual and reproductive healthcare providers’ opinions on expansion of pharmacy-led provision of contraception. BMJ Sex Reprod Health. 2019;45(3):183–189. doi:10.1136/bmjsrh-2018-200252.
   Web of Science ®Google Scholar
• Federfarma. [Internet]. La Farmacia Italiana 2022. [The Italian Pharmacy]. Available from: https://www.federfarma.it/Documenti/farmacia_italiana2022.aspx
   Google Scholar